Shattuck Labs
Keyi Xu is a Scientist with experience at Shattuck Labs since January 2022 and previously at Reynolds American Inc. from November 2020 to December 2021. Keyi Xu holds a Doctor of Philosophy (PhD) in Chemical Engineering and a Master's degree in Colloids, Polymers, and Surfaces, both from Carnegie Mellon University, where studies were completed between 2015 and 2020. Additionally, Keyi Xu earned a Bachelor of Engineering (BE) in Chemical Engineering from the University of Delaware, with studies completed from 2011 to 2015.
This person is not in any offices
Shattuck Labs
Shattuck is a clinical-stage biotechnology company pioneering the development of bifunctional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease.